Short Talk: Inhibition of Hepatocyte Inflammasome Improves Features of NASH in foz/foz Mice iconShort Talk: Inhibition of Hepatocyte Inflammasome Improves Features of NASH in foz/foz Mice

Short Talk: Inhibition of Hepatocyte Inflammasome Improves Features of NASH in foz/foz Mice

Mar 24, 2021 11:30am ‐ Mar 24, 2021 11:45am
Short Talk: Development of Liver-Targeted Interleukin-22 for Fatty Liver Disease iconShort Talk: Development of Liver-Targeted Interleukin-22 for Fatty Liver Disease

Short Talk: Development of Liver-Targeted Interleukin-22 for Fatty Liver Disease

Mar 24, 2021 11:45am ‐ Mar 24, 2021 12:00pm
[Joint Session] Networking and Social Hour icon[Joint Session] Networking and Social Hour

[Joint Session] Networking and Social Hour

Mar 24, 2021 12:00pm ‐ Mar 24, 2021 1:00pm
Short Talk: HHcy is a Feature and Mediator of NASH that Permits B12 and Folate to be an Effective Therapy for NASH iconShort Talk: HHcy is a Feature and Mediator of NASH that Permits B12 and Folate to be an Effective Therapy for NASH

Short Talk: HHcy is a Feature and Mediator of NASH that Permits B12 and Folate to be an Effective Therapy for NASH

Mar 24, 2021 12:00pm ‐ Mar 24, 2021 12:15pm
Closing Remarks iconClosing Remarks

Closing Remarks

Mar 24, 2021 12:15pm ‐ Mar 24, 2021 12:25pm
Fatty Liver Disease and Multi-System Complications | EK28 iconFatty Liver Disease and Multi-System Complications | EK28

Fatty Liver Disease and Multi-System Complications | EK28

Mar 24, 2021 1:00pm ‐ Mar 24, 2021 1:05pm